Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028
November 08, 2021 03:56 ET
|
Fortune Business Insights
Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
Sunshine Biopharma Files a Patent Application Covering mRNA Molecules for Treatment of Neurodegenerative Diseases
October 06, 2021 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Social Listening Provides a Gateway to Support and Connect with Multiple Sclerosis Patients in the US
September 15, 2021 04:53 ET
|
Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Unlocking Patient Insights in Multiple Sclerosis with Social Listening" report has been added to ResearchAndMarkets.com's offering. Gain a...
Multiple Sclerosis Drugs Market Size 2021-2028 | To Reach USD 41.99 Billion by 2028, Exhibiting a CAGR of 6.3 %
July 05, 2021 05:37 ET
|
Fortune Business Insights
Pune, India, July 05, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
AB Science fournit le résumé de la conférence virtuelle qui s’est tenue le 3 juin 2021 suite à l’interruption volontaire des études cliniques du masitinib
June 08, 2021 02:30 ET
|
AB Science
COMMUNIQUE DE PRESSE RESUME DE LA CONFERENCE VIRTUELLE DU 3 JUIN 2021 SUITE A L’INTERRUPTION VOLONTAIRE DES ETUDES CLINIQUES DU MASITINIB REPRISE DE LA COTATION MERCREDI 9 JUIN 2021 Paris, 8 juin...
AB Science is providing a summary of the live webcast held on June 3, 2021 following the voluntary hold in the clinical studies of masitinib
June 08, 2021 02:30 ET
|
AB Science
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON JUNE 3, 2021 FOLLOWING THE VOLUNTARY HOLD IN THE CLINICAL STUDIES OF MASITINIB RESUMPTION OF TRADING ON WEDNESDAY JUNE 9, 2021 Paris, June 8, 2021,...
Multiple Sclerosis Drugs Market Size 2021 | Is Projected to Reach USD 40.66 Billion by 2027, Exhibiting a CAGR of 7.1% during the Forecast Period
May 19, 2021 07:29 ET
|
Fortune Business Insights
Pune, India, May 19, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis market size is set to gain momentum as several prominent pharmaceutical companies are participating in conducting clinical...
Author Shares Unflinchingly Humorous Stories of Parenting Boys in Light-Hearted New Book
March 15, 2021 07:00 ET
|
Archway Publishing
CARMICHAEL, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Author and educator Kim Griffin has published her light-hearted and humorous collection of stories about her and her husband Patrick’s...
Dynamic Multiple Sclerosis Warrior, Mother, Yoga Instructor and Philanthropist Releases Raw and Inspiring Book in Time for MS Awareness Month
March 01, 2021 06:23 ET
|
Balboa Press
PHOENIX, March 01, 2021 (GLOBE NEWSWIRE) -- March is Multiple Sclerosis Awareness Month and in its honor, author and MS warrior Julie Blew has released the gripping account of her diagnosis and...
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
January 07, 2021 14:15 ET
|
BioNTech SE
Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA...